nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP1A2—Pentoxifylline—systemic scleroderma	0.157	0.355	CbGbCtD
Agomelatine—CYP1A2—Leflunomide—systemic scleroderma	0.149	0.339	CbGbCtD
Agomelatine—CYP2C9—Leflunomide—systemic scleroderma	0.135	0.305	CbGbCtD
Agomelatine—HTR2B—cardial valve—systemic scleroderma	0.0734	0.51	CbGeAlD
Agomelatine—CYP2C9—cardial valve—systemic scleroderma	0.0476	0.331	CbGeAlD
Agomelatine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00402	0.028	CbGeAlD
Agomelatine—HTR2B—skin of body—systemic scleroderma	0.00397	0.0276	CbGeAlD
Agomelatine—HTR2B—digestive system—systemic scleroderma	0.00318	0.0221	CbGeAlD
Agomelatine—HTR2B—tendon—systemic scleroderma	0.00302	0.021	CbGeAlD
Agomelatine—HTR2B—lung—systemic scleroderma	0.00265	0.0184	CbGeAlD
Agomelatine—CYP1A2—digestive system—systemic scleroderma	0.00217	0.0151	CbGeAlD
Agomelatine—CYP2C9—digestive system—systemic scleroderma	0.00206	0.0143	CbGeAlD
Agomelatine—CYP1A2—lung—systemic scleroderma	0.00181	0.0126	CbGeAlD
Agomelatine—Jaundice—Lisinopril—systemic scleroderma	0.00163	0.00391	CcSEcCtD
Agomelatine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00162	0.0039	CcSEcCtD
Agomelatine—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.00158	0.0038	CcSEcCtD
Agomelatine—Urticaria—Pentoxifylline—systemic scleroderma	0.00157	0.00379	CcSEcCtD
Agomelatine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00157	0.00377	CcSEcCtD
Agomelatine—Eye disorder—Mycophenolic acid—systemic scleroderma	0.00155	0.00374	CcSEcCtD
Agomelatine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00155	0.00373	CcSEcCtD
Agomelatine—Paraesthesia—Mometasone—systemic scleroderma	0.00153	0.0037	CcSEcCtD
Agomelatine—Dry mouth—Captopril—systemic scleroderma	0.00153	0.00369	CcSEcCtD
Agomelatine—Mental disorder—Leflunomide—systemic scleroderma	0.00153	0.00368	CcSEcCtD
Agomelatine—Dyspepsia—Mometasone—systemic scleroderma	0.0015	0.00362	CcSEcCtD
Agomelatine—Hepatitis—Lisinopril—systemic scleroderma	0.0015	0.0036	CcSEcCtD
Agomelatine—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00359	CcSEcCtD
Agomelatine—Hallucination—Lisinopril—systemic scleroderma	0.00149	0.00359	CcSEcCtD
Agomelatine—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00357	CcSEcCtD
Agomelatine—Fatigue—Mometasone—systemic scleroderma	0.00147	0.00355	CcSEcCtD
Agomelatine—Back pain—Leflunomide—systemic scleroderma	0.00147	0.00353	CcSEcCtD
Agomelatine—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00352	CcSEcCtD
Agomelatine—Infestation—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00352	CcSEcCtD
Agomelatine—Depression—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00351	CcSEcCtD
Agomelatine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00146	0.00351	CcSEcCtD
Agomelatine—Vision blurred—Leflunomide—systemic scleroderma	0.00143	0.00344	CcSEcCtD
Agomelatine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00343	CcSEcCtD
Agomelatine—Asthenia—Pentoxifylline—systemic scleroderma	0.00142	0.00342	CcSEcCtD
Agomelatine—Pruritus—Pentoxifylline—systemic scleroderma	0.0014	0.00338	CcSEcCtD
Agomelatine—Back pain—Mycophenolic acid—systemic scleroderma	0.0014	0.00337	CcSEcCtD
Agomelatine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.0014	0.00337	CcSEcCtD
Agomelatine—Tinnitus—Lisinopril—systemic scleroderma	0.0014	0.00336	CcSEcCtD
Agomelatine—Angioedema—Leflunomide—systemic scleroderma	0.00139	0.00334	CcSEcCtD
Agomelatine—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00333	CcSEcCtD
Agomelatine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00136	0.00328	CcSEcCtD
Agomelatine—Vertigo—Leflunomide—systemic scleroderma	0.00136	0.00328	CcSEcCtD
Agomelatine—Insomnia—Captopril—systemic scleroderma	0.00136	0.00327	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00136	0.00327	CcSEcCtD
Agomelatine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00136	0.00326	CcSEcCtD
Agomelatine—Tremor—Mycophenolic acid—systemic scleroderma	0.00136	0.00326	CcSEcCtD
Agomelatine—Abdominal pain—Mometasone—systemic scleroderma	0.00135	0.00325	CcSEcCtD
Agomelatine—Paraesthesia—Captopril—systemic scleroderma	0.00135	0.00325	CcSEcCtD
Agomelatine—Somnolence—Captopril—systemic scleroderma	0.00133	0.00321	CcSEcCtD
Agomelatine—Agitation—Mycophenolic acid—systemic scleroderma	0.00133	0.0032	CcSEcCtD
Agomelatine—Dyspepsia—Captopril—systemic scleroderma	0.00132	0.00318	CcSEcCtD
Agomelatine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00316	CcSEcCtD
Agomelatine—Mental disorder—Lisinopril—systemic scleroderma	0.00131	0.00316	CcSEcCtD
Agomelatine—Dizziness—Pentoxifylline—systemic scleroderma	0.00131	0.00316	CcSEcCtD
Agomelatine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00314	CcSEcCtD
Agomelatine—Infection—Azathioprine—systemic scleroderma	0.0013	0.00314	CcSEcCtD
Agomelatine—Vertigo—Mycophenolic acid—systemic scleroderma	0.0013	0.00313	CcSEcCtD
Agomelatine—Fatigue—Captopril—systemic scleroderma	0.00129	0.00312	CcSEcCtD
Agomelatine—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00129	0.0031	CcSEcCtD
Agomelatine—Anxiety—Leflunomide—systemic scleroderma	0.00129	0.0031	CcSEcCtD
Agomelatine—Constipation—Captopril—systemic scleroderma	0.00128	0.00309	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00128	0.00309	CcSEcCtD
Agomelatine—Skin disorder—Azathioprine—systemic scleroderma	0.00127	0.00307	CcSEcCtD
Agomelatine—Dry mouth—Leflunomide—systemic scleroderma	0.00126	0.00304	CcSEcCtD
Agomelatine—Back pain—Lisinopril—systemic scleroderma	0.00126	0.00304	CcSEcCtD
Agomelatine—Vomiting—Pentoxifylline—systemic scleroderma	0.00126	0.00303	CcSEcCtD
Agomelatine—Headache—Pentoxifylline—systemic scleroderma	0.00124	0.00299	CcSEcCtD
Agomelatine—Face oedema—Prednisone—systemic scleroderma	0.00124	0.00299	CcSEcCtD
Agomelatine—Infection—Leflunomide—systemic scleroderma	0.00123	0.00296	CcSEcCtD
Agomelatine—Vision blurred—Lisinopril—systemic scleroderma	0.00123	0.00296	CcSEcCtD
Agomelatine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00123	0.00296	CcSEcCtD
Agomelatine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00123	0.00296	CcSEcCtD
Agomelatine—Asthenia—Mometasone—systemic scleroderma	0.00123	0.00295	CcSEcCtD
Agomelatine—Irritability—Prednisone—systemic scleroderma	0.00123	0.00295	CcSEcCtD
Agomelatine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00295	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00122	0.00295	CcSEcCtD
Agomelatine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00294	CcSEcCtD
Agomelatine—Tremor—Lisinopril—systemic scleroderma	0.00122	0.00294	CcSEcCtD
Agomelatine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00121	0.00292	CcSEcCtD
Agomelatine—Pruritus—Mometasone—systemic scleroderma	0.00121	0.00291	CcSEcCtD
Agomelatine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.0012	0.0029	CcSEcCtD
Agomelatine—Skin disorder—Leflunomide—systemic scleroderma	0.0012	0.00289	CcSEcCtD
Agomelatine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.0012	0.00288	CcSEcCtD
Agomelatine—Hepatic failure—Methotrexate—systemic scleroderma	0.00119	0.00288	CcSEcCtD
Agomelatine—Angioedema—Lisinopril—systemic scleroderma	0.00119	0.00287	CcSEcCtD
Agomelatine—Abdominal pain—Captopril—systemic scleroderma	0.00119	0.00286	CcSEcCtD
Agomelatine—Nausea—Pentoxifylline—systemic scleroderma	0.00118	0.00283	CcSEcCtD
Agomelatine—Infection—Mycophenolic acid—systemic scleroderma	0.00117	0.00282	CcSEcCtD
Agomelatine—Vertigo—Lisinopril—systemic scleroderma	0.00117	0.00282	CcSEcCtD
Agomelatine—Diarrhoea—Mometasone—systemic scleroderma	0.00117	0.00282	CcSEcCtD
Agomelatine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00116	0.00279	CcSEcCtD
Agomelatine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00277	CcSEcCtD
Agomelatine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00115	0.00276	CcSEcCtD
Agomelatine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00114	0.00275	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00113	0.00272	CcSEcCtD
Agomelatine—Insomnia—Leflunomide—systemic scleroderma	0.00112	0.0027	CcSEcCtD
Agomelatine—Paraesthesia—Leflunomide—systemic scleroderma	0.00111	0.00268	CcSEcCtD
Agomelatine—Anxiety—Lisinopril—systemic scleroderma	0.00111	0.00266	CcSEcCtD
Agomelatine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00266	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.0011	0.00265	CcSEcCtD
Agomelatine—Dyspepsia—Leflunomide—systemic scleroderma	0.00109	0.00262	CcSEcCtD
Agomelatine—Vomiting—Mometasone—systemic scleroderma	0.00109	0.00262	CcSEcCtD
Agomelatine—Dry mouth—Lisinopril—systemic scleroderma	0.00108	0.00261	CcSEcCtD
Agomelatine—Asthenia—Captopril—systemic scleroderma	0.00108	0.00259	CcSEcCtD
Agomelatine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00107	0.00258	CcSEcCtD
Agomelatine—Headache—Mometasone—systemic scleroderma	0.00107	0.00258	CcSEcCtD
Agomelatine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00258	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00107	0.00257	CcSEcCtD
Agomelatine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00107	0.00257	CcSEcCtD
Agomelatine—Fatigue—Leflunomide—systemic scleroderma	0.00107	0.00257	CcSEcCtD
Agomelatine—Pruritus—Captopril—systemic scleroderma	0.00106	0.00256	CcSEcCtD
Agomelatine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00106	0.00255	CcSEcCtD
Agomelatine—Constipation—Leflunomide—systemic scleroderma	0.00106	0.00255	CcSEcCtD
Agomelatine—Infection—Lisinopril—systemic scleroderma	0.00106	0.00254	CcSEcCtD
Agomelatine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00105	0.00253	CcSEcCtD
Agomelatine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00253	CcSEcCtD
Agomelatine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00251	CcSEcCtD
Agomelatine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00104	0.0025	CcSEcCtD
Agomelatine—Abdominal pain—Azathioprine—systemic scleroderma	0.00104	0.00249	CcSEcCtD
Agomelatine—Skin disorder—Lisinopril—systemic scleroderma	0.00103	0.00249	CcSEcCtD
Agomelatine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00103	0.00248	CcSEcCtD
Agomelatine—Diarrhoea—Captopril—systemic scleroderma	0.00103	0.00247	CcSEcCtD
Agomelatine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00247	CcSEcCtD
Agomelatine—Irritability—Methotrexate—systemic scleroderma	0.00102	0.00247	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00102	0.00245	CcSEcCtD
Agomelatine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00102	0.00245	CcSEcCtD
Agomelatine—Nausea—Mometasone—systemic scleroderma	0.00102	0.00245	CcSEcCtD
Agomelatine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00101	0.00244	CcSEcCtD
Agomelatine—Weight increased—Prednisone—systemic scleroderma	0.00101	0.00243	CcSEcCtD
Agomelatine—Constipation—Mycophenolic acid—systemic scleroderma	0.00101	0.00243	CcSEcCtD
Agomelatine—Weight decreased—Prednisone—systemic scleroderma	0.001	0.00242	CcSEcCtD
Agomelatine—Dizziness—Captopril—systemic scleroderma	0.000993	0.00239	CcSEcCtD
Agomelatine—Depression—Prednisone—systemic scleroderma	0.000987	0.00238	CcSEcCtD
Agomelatine—Urticaria—Leflunomide—systemic scleroderma	0.000983	0.00237	CcSEcCtD
Agomelatine—Abdominal pain—Leflunomide—systemic scleroderma	0.000978	0.00236	CcSEcCtD
Agomelatine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000968	0.00233	CcSEcCtD
Agomelatine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000965	0.00233	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000965	0.00232	CcSEcCtD
Agomelatine—Insomnia—Lisinopril—systemic scleroderma	0.000962	0.00232	CcSEcCtD
Agomelatine—Paraesthesia—Lisinopril—systemic scleroderma	0.000955	0.0023	CcSEcCtD
Agomelatine—Vomiting—Captopril—systemic scleroderma	0.000955	0.0023	CcSEcCtD
Agomelatine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00095	0.00229	CcSEcCtD
Agomelatine—Somnolence—Lisinopril—systemic scleroderma	0.000945	0.00228	CcSEcCtD
Agomelatine—Headache—Captopril—systemic scleroderma	0.000941	0.00227	CcSEcCtD
Agomelatine—Dyspepsia—Lisinopril—systemic scleroderma	0.000936	0.00225	CcSEcCtD
Agomelatine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000933	0.00225	CcSEcCtD
Agomelatine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000926	0.00223	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000918	0.00221	CcSEcCtD
Agomelatine—Fatigue—Lisinopril—systemic scleroderma	0.000917	0.00221	CcSEcCtD
Agomelatine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000914	0.0022	CcSEcCtD
Agomelatine—Constipation—Lisinopril—systemic scleroderma	0.000909	0.00219	CcSEcCtD
Agomelatine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000905	0.00218	CcSEcCtD
Agomelatine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000901	0.00217	CcSEcCtD
Agomelatine—Diarrhoea—Azathioprine—systemic scleroderma	0.000897	0.00216	CcSEcCtD
Agomelatine—Nausea—Captopril—systemic scleroderma	0.000892	0.00215	CcSEcCtD
Agomelatine—Asthenia—Leflunomide—systemic scleroderma	0.000888	0.00214	CcSEcCtD
Agomelatine—Hallucination—Prednisone—systemic scleroderma	0.000884	0.00213	CcSEcCtD
Agomelatine—Pruritus—Leflunomide—systemic scleroderma	0.000875	0.00211	CcSEcCtD
Agomelatine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000873	0.0021	CcSEcCtD
Agomelatine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000869	0.00209	CcSEcCtD
Agomelatine—Dizziness—Azathioprine—systemic scleroderma	0.000866	0.00209	CcSEcCtD
Agomelatine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000847	0.00204	CcSEcCtD
Agomelatine—Diarrhoea—Leflunomide—systemic scleroderma	0.000847	0.00204	CcSEcCtD
Agomelatine—Urticaria—Lisinopril—systemic scleroderma	0.000845	0.00203	CcSEcCtD
Agomelatine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000843	0.00203	CcSEcCtD
Agomelatine—Abdominal pain—Lisinopril—systemic scleroderma	0.000841	0.00202	CcSEcCtD
Agomelatine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000837	0.00201	CcSEcCtD
Agomelatine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000835	0.00201	CcSEcCtD
Agomelatine—Vomiting—Azathioprine—systemic scleroderma	0.000833	0.00201	CcSEcCtD
Agomelatine—Eye disorder—Prednisone—systemic scleroderma	0.000831	0.002	CcSEcCtD
Agomelatine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000828	0.00199	CcSEcCtD
Agomelatine—Infestation NOS—Methotrexate—systemic scleroderma	0.000827	0.00199	CcSEcCtD
Agomelatine—Infestation—Methotrexate—systemic scleroderma	0.000827	0.00199	CcSEcCtD
Agomelatine—Depression—Methotrexate—systemic scleroderma	0.000825	0.00199	CcSEcCtD
Agomelatine—Headache—Azathioprine—systemic scleroderma	0.000821	0.00198	CcSEcCtD
Agomelatine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00082	0.00198	CcSEcCtD
Agomelatine—Dizziness—Leflunomide—systemic scleroderma	0.000818	0.00197	CcSEcCtD
Agomelatine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000808	0.00195	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000804	0.00194	CcSEcCtD
Agomelatine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000797	0.00192	CcSEcCtD
Agomelatine—Vomiting—Leflunomide—systemic scleroderma	0.000787	0.0019	CcSEcCtD
Agomelatine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000783	0.00188	CcSEcCtD
Agomelatine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000781	0.00188	CcSEcCtD
Agomelatine—Mental disorder—Prednisone—systemic scleroderma	0.000779	0.00188	CcSEcCtD
Agomelatine—Nausea—Azathioprine—systemic scleroderma	0.000778	0.00187	CcSEcCtD
Agomelatine—Headache—Leflunomide—systemic scleroderma	0.000775	0.00187	CcSEcCtD
Agomelatine—Asthenia—Lisinopril—systemic scleroderma	0.000763	0.00184	CcSEcCtD
Agomelatine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000762	0.00183	CcSEcCtD
Agomelatine—Pruritus—Lisinopril—systemic scleroderma	0.000752	0.00181	CcSEcCtD
Agomelatine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000751	0.00181	CcSEcCtD
Agomelatine—Hepatitis—Methotrexate—systemic scleroderma	0.000743	0.00179	CcSEcCtD
Agomelatine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00178	CcSEcCtD
Agomelatine—Headache—Mycophenolic acid—systemic scleroderma	0.00074	0.00178	CcSEcCtD
Agomelatine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000736	0.00177	CcSEcCtD
Agomelatine—Nausea—Leflunomide—systemic scleroderma	0.000735	0.00177	CcSEcCtD
Agomelatine—Vision blurred—Prednisone—systemic scleroderma	0.000729	0.00176	CcSEcCtD
Agomelatine—Diarrhoea—Lisinopril—systemic scleroderma	0.000727	0.00175	CcSEcCtD
Agomelatine—Agitation—Prednisone—systemic scleroderma	0.000711	0.00171	CcSEcCtD
Agomelatine—Angioedema—Prednisone—systemic scleroderma	0.000707	0.0017	CcSEcCtD
Agomelatine—Dizziness—Lisinopril—systemic scleroderma	0.000703	0.00169	CcSEcCtD
Agomelatine—Nausea—Mycophenolic acid—systemic scleroderma	0.000701	0.00169	CcSEcCtD
Agomelatine—Vertigo—Prednisone—systemic scleroderma	0.000695	0.00167	CcSEcCtD
Agomelatine—Eye disorder—Methotrexate—systemic scleroderma	0.000694	0.00167	CcSEcCtD
Agomelatine—Tinnitus—Methotrexate—systemic scleroderma	0.000693	0.00167	CcSEcCtD
Agomelatine—Vomiting—Lisinopril—systemic scleroderma	0.000676	0.00163	CcSEcCtD
Agomelatine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000668	0.00161	CcSEcCtD
Agomelatine—Headache—Lisinopril—systemic scleroderma	0.000666	0.0016	CcSEcCtD
Agomelatine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000659	0.00159	CcSEcCtD
Agomelatine—Anxiety—Prednisone—systemic scleroderma	0.000656	0.00158	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000654	0.00158	CcSEcCtD
Agomelatine—Mental disorder—Methotrexate—systemic scleroderma	0.000651	0.00157	CcSEcCtD
Agomelatine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000637	0.00154	CcSEcCtD
Agomelatine—Nausea—Lisinopril—systemic scleroderma	0.000632	0.00152	CcSEcCtD
Agomelatine—Infection—Prednisone—systemic scleroderma	0.000627	0.00151	CcSEcCtD
Agomelatine—Back pain—Methotrexate—systemic scleroderma	0.000625	0.00151	CcSEcCtD
Agomelatine—Nervous system disorder—Prednisone—systemic scleroderma	0.000619	0.00149	CcSEcCtD
Agomelatine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000616	0.00148	CcSEcCtD
Agomelatine—Skin disorder—Prednisone—systemic scleroderma	0.000613	0.00148	CcSEcCtD
Agomelatine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00061	0.00147	CcSEcCtD
Agomelatine—Vision blurred—Methotrexate—systemic scleroderma	0.000609	0.00147	CcSEcCtD
Agomelatine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000592	0.00143	CcSEcCtD
Agomelatine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000584	0.00141	CcSEcCtD
Agomelatine—Vertigo—Methotrexate—systemic scleroderma	0.000581	0.0014	CcSEcCtD
Agomelatine—Insomnia—Prednisone—systemic scleroderma	0.000571	0.00138	CcSEcCtD
Agomelatine—Paraesthesia—Prednisone—systemic scleroderma	0.000567	0.00137	CcSEcCtD
Agomelatine—Dyspepsia—Prednisone—systemic scleroderma	0.000556	0.00134	CcSEcCtD
Agomelatine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000553	0.00133	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000547	0.00132	CcSEcCtD
Agomelatine—Fatigue—Prednisone—systemic scleroderma	0.000544	0.00131	CcSEcCtD
Agomelatine—Constipation—Prednisone—systemic scleroderma	0.00054	0.0013	CcSEcCtD
Agomelatine—Infection—Methotrexate—systemic scleroderma	0.000524	0.00126	CcSEcCtD
Agomelatine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000518	0.00125	CcSEcCtD
Agomelatine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000516	0.00124	CcSEcCtD
Agomelatine—Skin disorder—Methotrexate—systemic scleroderma	0.000513	0.00123	CcSEcCtD
Agomelatine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00051	0.00123	CcSEcCtD
Agomelatine—Urticaria—Prednisone—systemic scleroderma	0.000502	0.00121	CcSEcCtD
Agomelatine—Abdominal pain—Prednisone—systemic scleroderma	0.000499	0.0012	CcSEcCtD
Agomelatine—Insomnia—Methotrexate—systemic scleroderma	0.000477	0.00115	CcSEcCtD
Agomelatine—Paraesthesia—Methotrexate—systemic scleroderma	0.000474	0.00114	CcSEcCtD
Agomelatine—Somnolence—Methotrexate—systemic scleroderma	0.000469	0.00113	CcSEcCtD
Agomelatine—Dyspepsia—Methotrexate—systemic scleroderma	0.000465	0.00112	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000456	0.0011	CcSEcCtD
Agomelatine—Fatigue—Methotrexate—systemic scleroderma	0.000455	0.0011	CcSEcCtD
Agomelatine—Asthenia—Prednisone—systemic scleroderma	0.000453	0.00109	CcSEcCtD
Agomelatine—Pruritus—Prednisone—systemic scleroderma	0.000447	0.00108	CcSEcCtD
Agomelatine—Diarrhoea—Prednisone—systemic scleroderma	0.000432	0.00104	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000432	0.00104	CcSEcCtD
Agomelatine—Urticaria—Methotrexate—systemic scleroderma	0.000419	0.00101	CcSEcCtD
Agomelatine—Dizziness—Prednisone—systemic scleroderma	0.000418	0.00101	CcSEcCtD
Agomelatine—Abdominal pain—Methotrexate—systemic scleroderma	0.000417	0.001	CcSEcCtD
Agomelatine—Vomiting—Prednisone—systemic scleroderma	0.000402	0.000967	CcSEcCtD
Agomelatine—Headache—Prednisone—systemic scleroderma	0.000396	0.000953	CcSEcCtD
Agomelatine—Asthenia—Methotrexate—systemic scleroderma	0.000379	0.000912	CcSEcCtD
Agomelatine—Nausea—Prednisone—systemic scleroderma	0.000375	0.000903	CcSEcCtD
Agomelatine—Pruritus—Methotrexate—systemic scleroderma	0.000373	0.000899	CcSEcCtD
Agomelatine—Diarrhoea—Methotrexate—systemic scleroderma	0.000361	0.00087	CcSEcCtD
Agomelatine—Dizziness—Methotrexate—systemic scleroderma	0.000349	0.000841	CcSEcCtD
Agomelatine—Vomiting—Methotrexate—systemic scleroderma	0.000336	0.000808	CcSEcCtD
Agomelatine—Headache—Methotrexate—systemic scleroderma	0.000331	0.000796	CcSEcCtD
Agomelatine—Nausea—Methotrexate—systemic scleroderma	0.000313	0.000755	CcSEcCtD
